Pregnancy and phaeochromocytoma/paraganglioma: clinical clues affecting diagnosis and outcome – a systematic review

Author:

Langton K12ORCID,Tufton N3,Akker S3,Deinum J245,Eisenhofer G124,Timmers HJLM5,Spaanderman MEA67,Lenders JWM245

Affiliation:

1. Institute of Clinical Chemistry and Laboratory Medicine University Hospital Carl Gustav Carus Dresden Germany

2. Medical Faculty Technical University Dresden Dresden Germany

3. Department of Endocrinology St Bartholomew’s Hospital Bart’s Health NHS Trust London UK

4. Department of Medicine III University Hospital Carl Gustav Carus Dresden Germany

5. Department of Internal Medicine Radboud University Medical Center Nijmegen The Netherlands

6. Department of Obstetrics and Gynaecology Maastricht University Medical Centre (MUMC) Maastricht The Netherlands

7. Department of Obstetrics and Gynaecology Radboud University Medical Centre Nijmegen The Netherlands

Abstract

BackgroundPhaeochromocytoma and paraganglioma (PPGL) in pregnancy, if not diagnosed antepartum, pose a high risk for mother and child.ObjectiveTo examine the clinical clues of antepartum and postpartum/postmortem diagnosis of PPGL.Search strategyCase reports on PPGL in pregnancy published between 1 January 1988 and 30 June 2019 in English, German, Dutch or French.Selection criteriaCase reports containing a predefined minimum of clinical data on PPGL and pregnancy.Data collection and analysisTwo authors independently performed data extraction and assessed data quality. We calculated odds ratios (OR) (with 95% confidence intervals) and used uni‐ and multivariable logistic regression analysis.Main resultsMaternal and fetal/neonatal mortalities were 9.0% (18/200) and 14.2% (29/204), respectively. Maternal mortality was 42‐fold higher with PPGL diagnosed postpartum/postmortem (17/58; 29.3%) than antepartum (1/142; 0.7%) (adjusted OR 45.9, 95% CI 5.67–370, P = 0.0003). Offspring mortality was 2.6‐fold higher with PPGL diagnosed postpartum/postmortem than antepartum (OR 3.1, 95% CI 1.38–6.91, P = 0.0044). Hypertension at admission (OR 2.29, 95% CI 1.12–4.68, P = 0.022), sweating (OR 3.14, 95% CI 1.29–7.63, P = 0.014) and a history of PPGL, a known PPGL‐associated gene mutation or adrenal mass (OR 8.87, 95% CI 1.89–41.64, P = 0.0056) were independent factors of antepartum diagnosis. Acute onset of symptoms (OR 8.49, 95% CI 3.52–20.5, P < 0.0001), initial diagnosis of pre‐eclampsia (OR 6.34, 95% CI 2.60–15.5, P < 0.0001), admission for obstetric care (OR 10.71, 95% CI 2.70–42.45, P = 0.0007) and maternal tachycardia (OR 2.72, 95% CI 1.26–5.85, P = 0.011) were independent factors of postpartum diagnosis.ConclusionSeveral clinical clues can assist clinicians in considering an antenatal diagnosis of PPGL in pregnancy, thus potentially improving outcome.Tweetable abstractSystematic review of 204 pregnant patients with phaeochromocytoma identified clinical clues for a timely antepartum diagnosis.

Publisher

Wiley

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Bladder paraganglioma in pregnancy with a successful perinatal outcome: a case report;BJR|Case Reports;2025-04-29

2. Paraganglioma in Pregnancy with Recurrent Pregnancy Loss;Journal of the ASEAN Federation of Endocrine Societies;2025-04-25

3. Paragangliome et grossesse : une histoire mictionnelle palpitante;Gynécologie Obstétrique Fertilité & Sénologie ;2025-01

4. Update on clinical characteristics in the evaluation of phaeochromocytoma and paraganglioma;Best Practice & Research Clinical Endocrinology & Metabolism;2024-12

5. Pharmacotherapeutic options for the treatment of hypertension in pregnancy;Expert Opinion on Pharmacotherapy;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3